Unfolded protein response

WikiDoc Resources for Unfolded protein response

Articles

Most recent articles on Unfolded protein response

Most cited articles on Unfolded protein response

Review articles on Unfolded protein response

Articles on Unfolded protein response in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Unfolded protein response

Images of Unfolded protein response

Photos of Unfolded protein response

Podcasts & MP3s on Unfolded protein response

Videos on Unfolded protein response

Evidence Based Medicine

Cochrane Collaboration on Unfolded protein response

Bandolier on Unfolded protein response

TRIP on Unfolded protein response

Clinical Trials

Ongoing Trials on Unfolded protein response at Clinical Trials.gov

Trial results on Unfolded protein response

Clinical Trials on Unfolded protein response at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Unfolded protein response

NICE Guidance on Unfolded protein response

NHS PRODIGY Guidance

FDA on Unfolded protein response

CDC on Unfolded protein response

Books

Books on Unfolded protein response

News

Unfolded protein response in the news

Be alerted to news on Unfolded protein response

News trends on Unfolded protein response

Commentary

Blogs on Unfolded protein response

Definitions

Definitions of Unfolded protein response

Patient Resources / Community

Patient resources on Unfolded protein response

Discussion groups on Unfolded protein response

Patient Handouts on Unfolded protein response

Directions to Hospitals Treating Unfolded protein response

Risk calculators and risk factors for Unfolded protein response

Healthcare Provider Resources

Symptoms of Unfolded protein response

Causes & Risk Factors for Unfolded protein response

Diagnostic studies for Unfolded protein response

Treatment of Unfolded protein response

Continuing Medical Education (CME)

CME Programs on Unfolded protein response

International

Unfolded protein response en Espanol

Unfolded protein response en Francais

Business

Unfolded protein response in the Marketplace

Patents on Unfolded protein response

Experimental / Informatics

List of terms related to Unfolded protein response

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview[edit | edit source]

The unfolded protein response (UPR) is a cellular stress response related to the endoplasmic reticulum. It is a stress response that has been found to be conserved between all mammalian species, as well as yeast and worm organisms. This article focuses on the mammalian response.

The UPR is activated in response to an accumulation of unfolded or misfolded proteins in the lumen of the endoplasmic reticulum. In this scenario, the UPR has two primary aims: initially to restore normal function of the cell by halting protein translation and activate the signaling pathways that lead to increasing the production of molecular chaperones involved in protein folding. If these objectives are not achieved within a certain time lapse or the disruption is prolonged, the UPR aims towards apoptosis.

Sustained overactivation of the UPR has been implicated in prion diseases as well as several other neurodegenerative diseases, and inhibiting the UPR could become a treatment for those diseases.[1] Diseases subject to UPR inhibition include Creutzfeldt-Jakob disease, Alzheimer's disease, Parkinson's disease, and Huntington's disease.[2]

## Protein folding in the endoplasmic reticulum[edit | edit source]

### Protein synthesis[edit | edit source]

The term protein folding incorporates all the processes involved in the production of a protein after the nascent polypeptides have become synthesized by the ribosomes. The proteins destined to be secreted or sorted to other cell organelles carry an N-terminal signal sequence that will interact with a signal recognition particle (SRP). The SRP will lead the whole complex (Ribosome, RNA, polypeptide) to the ER membrane. Once the sequence has “docked”, the protein continues translation, with the resultant strand being fed through the polypeptide translocator directly into the ER. Protein folding commences as soon as the polypeptide enters to the luminal environment, even as translation of the remaining polypeptide continues.

### Protein folding and quality control[edit | edit source]

Protein folding steps involve a range of enzymes and molecular chaperones to coordinate and regulate reactions, in addition to a range of substrates required in order for the reactions to take place. The most important of these to note are N-linked glycosylation and disulfide bond formation. N-linked glycosylation occurs as soon as the protein sequence passes into the ER through the translocon, where it is glycosylated with a sugar molecule that forms the key ligand for the lectin molecules calreticulin (CRT; soluble in ER lumen) and calnexin (CNX; membrane bound)1. Favoured by the highly oxidizing environment of the ER, protein disulfide isomerases facilitate formation of disulfide bonds, which confer structural stability to the protein in order for it to withstand adverse conditions such as extremes of pH and degradative enzymes.

The ER is capable of recognizing malfolding proteins without causing disruption to the functioning of the ER. The aforementioned sugar molecule remains the means by which the cell monitors protein folding, as the malfolding protein becomes characteristically devoid of glucose residues, targeting it for identification and re-glycosylation by the enzyme UGGT (UGT-glucose:glycoprotein glucosyltransferase)1. If this fails to restore the normal folding process, exposed hydrophobic residues of the malfolded protein are bound by the protein glucose regulate protein 78 (Grp78), a heat shock protein 70kDa family member2 that prevents the protein from further transit and secretion3.

Where circumstances continue to cause a particular protein to malfold, the protein is recognized as posing a threat to the proper functioning of the ER, as they can aggregate to one another and accumulate. In such circumstances the protein is guided through endoplasmic reticulum-associated degradation (ERAD). The chaperone EDEM guides the retrotranslocation of the malfolded protein back into the cytosol in transient complexes with PDI and Grp784. Here it enters the ubiquitin-proteasome pathway, as it is tagged by multiple ubiquitin molecules, targeting it for degradation by cytosolic proteasomes.

Successful protein folding requires a tightly controlled environment of substrates that include glucose to meet the metabolic energy requirements of the functioning molecular chaperones; calcium that is stored bound to resident molecular chaperones and; redox buffers that maintain the oxidizing environment required for disulfide bond formation5.

Unsuccessful Protein folding can be caused by HLA-B27, disturbing balance of important (IL-10 and TNF) signaling proteins. At least some disturbance are relianced on correct HLA-B27 folding. [3]

However where circumstances cause a more global disruption to protein folding that overwhelms the ER’s coping mechanisms, the UPR is activated.

## Molecular mechanism[edit | edit source]

### Initiation[edit | edit source]

The molecular chaperone BiP/Grp78 has a range of functions within the ER. It maintains specific transmembrane receptor proteins involved in initiating of the downstream signalling of the UPR in an inactive state by binding to their luminal domains. An overwhelming load of misfolded proteins or simply the over-expression of proteins (e.g. IgG)[4] requires more of the available BiP/Grp78 to bind to the exposed hydrophobic regions of these proteins, and consequently BiP/Grp78 dissociates from these receptors sites to meet this requirement. Dissociation from the intracellular receptor domains allows them to become active. PERK dimerizes with BiP in resting cells and oligomerizes in ER-stressed cells.

Although this is traditionally the accepted model, doubts have been raised over its validity. It has been argued that the genetic and structural evidence supporting the model simply shows BiP dissociation to be merely correlated with Ire1 activation, rather than specifically causing it.[5] An alternative model has been proposed, whereby unfolded proteins interact directly with the ER-lumenal domain of Ire1, causing oligomerization and transautophosphorylation.[5]

### Functions[edit | edit source]

The initial phases of UPR activation have two key roles:

Translation Attenuation and Cell Cycle Arrest by the PERK Receptor

This occurs within minutes to hours of UPR activation to prevent further translational loading of the ER. PERK (protein kinase RNA-like endoplasmic reticulum kinase) activates itself by oligomerization and autophosphorylation of the free luminal domain. The activated cytosolic domain causes translational attenuation by directly phosphorylating the α subunit of the regulating initiator of the mRNA translation machinery, eIF2. This also produces translational attenuation of the protein machinery involved in running the cell cycle, producing cell cycle arrest in the G1 phase. PERK deficiency may have a significant impact on physiological states associated with ER stress.

Increased Production of Proteins Involved in the Functions of the UPR

UPR activation also results in upregulation of proteins involved in chaperoning malfolding proteins, protein folding and ERAD, including further production of Grp78. Ultimately this increases the cell’s molecular mechanisms by which it can deal with the malfolded protein load. These receptor proteins have been identified as:
• Inositol-requiring kinase 1, whose free luminal domain activates itself by homodimerisation and transautophosphorylation. The activated domain is able to activate the transcription factor XBP1 (Xbox binding protein) mRNA (the mammalian equivalent of the yeast Hac1 mRNA) by cleavage and removal of a 252bp intron. The activated transcription factor upregulates UPR ‘stress genes’ by directly binding to stress element promoters in the nucleus.
• ATF6 (activating transcription factor 6) is a basic leucine zipper transcription factor. Upon Grp78 dissociation the entire 90kDa protein translocates to the Golgi, where it is cleaved by proteases to form an active 50kDa transcription factor that translocates to the nucleus. It binds to stress element promoters upstream of genes that are upregulated in the UPR.

The aim of these responses is to remove the accumulated protein load whilst preventing any further addition to the stress, so that normal function of the ER can be restored as soon as possible.

If the UPR pathway is activated in an abnormal fashion, such as when obesity triggers chronic ER stress and the pathway is constitutively active, this can lead to insensitivity to insulin signaling and thus insulin resistance. Individuals suffering from obesity have an elevated demand placed on the secretory and synthesis systems of their cells. This activates cellular stress signaling and inflammatory pathways because of the abnormal conditions disrupting ER homeostasis.

A downstream effect of the ER stress is a significant decrease in insulin-stimulated phosphorylation of Tyrosine residues of insulin receptor substrate (IRS-1), which is the substrate for insulin tyrosine kinase (the insulin receptor). C-Jun N-terminal kinase (JNK) is also activated at high levels by IRE-1α, which itself is phosphorylated to become activated in the presence of ER stress. Subsequently, JNK phosphorlyates Serine residues of IRS-1, and thus inhibits insulin receptor signaling. IRE-1α also recruits tumor necrosis factor receptor-associated factor 2 (TRAF2). This kinase cascade that is dependent on IRE-1α and JNK mediates ER stress–induced inhibition of insulin action.[6]

Obesity provides chronic cellular stimuli for the UPR pathway as a result of the stresses and strains placed upon the ER, and without allowing restoration to normal cellular responsiveness to insulin hormone signaling, an individual becomes very likely to develop Type 2 Diabetes.

Skeletal muscles are sensitive to physiological stress, as exercise can impair ER homeostasis. This causes the expression of ER chaperones to be induced by the UPR in response to the exercise-induced ER stress. Muscular contraction during exercise causes calcium to be released from the sarcoplasmic reticulum (SR), a specialized ER network in skeletal muscles. This calcium then interacts with calcineurin and calcium/calmodulin-dependent kinases that in turn activate transcription factors. These transcription factors then proceed to alter the expression of exercise-regulated muscle genes. PGC-1alpha, a transcriptional coactivator, is a key transcription factor involved in mediating the UPR in a tissue-specific manner in skeletal muscles by coactivating ATF6alpha. Therefore, PGC-1alpha gets expressed in muscles after acute and long-term exercise training. The function of this transcription factor is to increase the number and function of mitochondria, as well as to induce a switch of skeletal fibers to slow oxidative muscle fibers, as these are fatigue-resistant. Therefore, this UPR pathway mediates changes in muscles that have undergone endurance training by making them more resistant to fatigue and protecting them from future stress.[7]

### Initiating apoptosis[edit | edit source]

In conditions of prolonged stress, the goal of the UPR changes from being one that promotes cellular survival to one that commits the cell to a pathway of apoptosis. Proteins downstream of all 3 UPR receptor pathways have been identified as having pro-apoptotic roles. However, the point at which the ‘apoptotic switch’ is activated has not yet been determined, but it is a logical consideration that this should be beyond a certain time period in which resolution of the stress has not been achieved. The 2 principal UPR receptors involved are Ire1 and PERK.

By binding with the protein TRAF2, Ire1 activates a JNK signaling pathway, at which point human procaspase 4 is believed to cause apoptosis by activating downstream caspases.

Although PERK is recognised to produce a translational block, certain genes can bypass this block. An important example is that the proapoptotic protein CHOP (CCAAT/-enhancer-binding protein homologous protein), is upregulated downstream of the bZIP transcription factor ATF4 (activating transcription factor 4) and uniquely responsive to ER stress15. CHOP causes downregulation of the anti-apoptotic mitochondrial protein Bcl-216, favouring a pro-apoptotic drive at the mitochondria by proteins that cause mitochondrial damage, cytochrome c release and caspase 3 activation.

## Chemical inducers[edit | edit source]

* Brefeldin A is a very common inducer of the unfolded protein response or ER stress.
* thapsigargin [8] Leads to ER Ca+2 depletion due to inhibition of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA).
* A23187 [8]
* 2-deoxyglucose [8]
* dithiothreitol [8] Reduce the disulfide bridges of proteins. The denatured proteins accumulated inside the ER.
* fenretinide and bortezomib (Velcade), each acting via different cellular mechanisms, induce ER stress leading to apoptosis in melanoma cells.
* tunicamycin most notably UPR inducer.

## References[edit | edit source]

1. ↑ Julie A. Moreno; et al. (2013). "Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice". Sci Transl Med. 5 (206): 138. doi:10.1126/scitranslmed.3006767. Unknown parameter `|month=` ignored (help)CS1 maint: Explicit use of et al. (link)
2. ↑ BBC Health News (10.10.2013). "Alzheimer's breakthrough hailed as 'turning point'". British Broadcasting Co. Retrieved 10.10.2013. Check date values in: `|accessdate=, |date=` (help)
3. ↑ LL Markus Penttinen. "HLA-B27 associated with debilitated salmonella bacteria resistance" (in Finnish). Turku University Library: Ann. Univ. Turkuensis D 619. ISBN 951-29-2742-X. Retrieved 10.09.2012. Unknown parameter `|datum=` ignored (`|date=` suggested) (help); Check date values in: `|accessdate=` (help)CS1 maint: Unrecognized language (link)
4. ↑ Kober L, Zehe C, Bode J (2012). "Development of a novel ER stress based selection system for the isolation of highly productive clones". Biotechnol. Bioeng. 109 (10): 2599–611. doi:10.1002/bit.24527. PMID 22510960. Unknown parameter `|month=` ignored (help)CS1 maint: Multiple names: authors list (link)
5. ↑ 5.0 5.1 Bernales, Papa and Walter (2006). Intracellular signaling by the unfolded protein response. Annual Review of Cell and Developmental Biology, 22: 487–508
6. ↑ Ozcan, Umut (15). "Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes". Science. 306: 457–461. Unknown parameter `|coauthors=` ignored (help); Unknown parameter `|month=` ignored (help); Check date values in: `|date=, |year= / |date= mismatch` (help); `|access-date=` requires `|url=` (help)
7. ↑ Wu, Jun (2011). "The Unfolded Protein Response Mediates Adaptation to Exercise in Skeletal Muscle through a PGC-1alpha/ATF6alpha Complex". Cell Metabolism (13): 160–169. Unknown parameter `|month=` ignored (help)
8. ↑ 8.0 8.1 8.2 8.3 Kitamura,M

## Further reading[edit | edit source]

1. Blond-Elguindi, S., Cwiria, SE., Dower, WJ., Lipshutz, RJ., Sprang, SR., Sambrook, JF., Gething, MH (1993) Cell 75: 717-728
2. Brewer, J., Diehl, J. (2000) Proc Natl Acad USA 97 (23): 12625-30
3. Chen, X., Shen, J., Prywes, R. (2002) J Biol Chem 277 (15): 13045-53
4. Cox, JS., Shamu, CE., Walter, P. (1993) Cell 73 (6): 1197-1206
5. Hammond, C., Braakman, I., Helenius, A. 1994 PNAS 91: 913-917
6. Harding, H. P., Zhang, Y., Ron, D. (1999) Nature 397 271-4
7. Lee, A-H., Iwakoshi, N., Anderson, K., Glimcher, L. (2003) Proc Natl Acad Sci USA 100 (17) 9946-51
8. Lee, AS (1987) Trends Biochem Sci 12 20-23
9. Machamer, CE., Doms, RW., Bole, DG,. Helenius, A., Rose, JK. (1990) J Biol Chem 265 (12) 6879-6883
10. McCullough, K., Martindale, J., Klotz, L., Aw, T., Holbrook, N (2001) Mol Cell Biol 21: 1249-1259
11. Molinari, M., Galli, C., Piccaluga, V., Pieren, M., Paganetti, P. (2002) J Cell Biol 158 (2) 247-257
12. Mori, K., Ogawa, O., Kawahara, T., Yanagi, H., Yura, T. (2000) Proc Natl Acad Sci USA 97 4660-4665
13. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H., Ron, D (2000) Science 287 (5453) 664-666
14. Wang, X-Z., Lawson, B., Brewer, J. W., Zinszner, H., Sanjay, A., Mi, L., Boorstein, R., Kreibich, G., Hendershot, L., Ron., D. (1996) Mol Cell Biol 16 (8) 4273-80
15. Welihinda, A. A., Kaufman, R. J. (1996) J Biol Chem 271 (30) 18181-7
16. Yoshida, H., Haze, K., Yanagi, H., Yura, T., Mori, K. (1998) J Biol Chem 273 (50): 33741-9

Template:WikiDoc Sources